Literature DB >> 12362025

Coffin-Lowry syndrome: clinical and molecular features.

A Hanauer1, I D Young.   

Abstract

The Coffin-Lowry syndrome (CLS) is a rare X linked disorder in which affected males show severe mental retardation with characteristic dysmorphism, most notably affecting the face and hands. The typical facial features consist of a prominent forehead, hypertelorism, a flat nasal bridge, downward sloping palpebral fissures, and a wide mouth with full lips. Mild progression in facial coarsening occurs during childhood and adult life. The hands are broad with soft, stubby, tapering fingers. Other clinical findings include short stature (95%), a pectus deformity (80%), a kyphosis and/or scoliosis (80%), mitral valve dysfunction, and sensorineural hearing loss. The causal gene, RSK2, was identified in 1996 and contains 22 exons which encode a protein of 740 amino acids. Over 75 distinct pathogenic mutations have been identified in 250 unrelated CLS patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12362025      PMCID: PMC1734994          DOI: 10.1136/jmg.39.10.705

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  65 in total

1.  The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k.

Authors:  S R von Manteuffel; P B Dennis; N Pullen; A C Gingras; N Sonenberg; G Thomas
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  The radiology of Coffin-Lowry syndrome.

Authors:  S Padley; S V Hodgson; T Sherwood
Journal:  Br J Radiol       Date:  1990-01       Impact factor: 3.039

3.  Drop episodes in Coffin-Lowry syndrome: exaggerated startle responses treated with clonazepam.

Authors:  M Nakamura; T Yamagata; M Y Momoi; T Yamazaki
Journal:  Pediatr Neurol       Date:  1998-08       Impact factor: 3.372

4.  "Cataplexy" and muscle ultrasound abnormalities in Coffin-Lowry syndrome.

Authors:  Y J Crow; S M Zuberi; R McWilliam; J L Tolmie; A Hollman; K Pohl; J B Stephenson
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

5.  Coffin-Lowry syndrome: a multicenter study.

Authors:  S Gilgenkrantz; P Mujica; P Gruet; P Tridon; F Schweitzer; A Nivelon-Chevallier; J L Nivelon; G Couillault; A David; A Verloes
Journal:  Clin Genet       Date:  1988-10       Impact factor: 4.438

6.  Probable localisation of the Coffin-Lowry locus in Xp22.2-p22.1 by multipoint linkage analysis.

Authors:  A Hanauer; Y Alembik; S Gilgenkrantz; P Mujica; A Nivelon-Chevallier; M E Pembrey; I D Young; J L Mandel
Journal:  Am J Med Genet       Date:  1988 May-Jun

7.  Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK.

Authors:  K N Dalby; N Morrice; F B Caudwell; J Avruch; P Cohen
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

Review 8.  CREB and memory.

Authors:  A J Silva; J H Kogan; P W Frankland; S Kida
Journal:  Annu Rev Neurosci       Date:  1998       Impact factor: 12.449

9.  Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene.

Authors:  D De Cesare; S Jacquot; A Hanauer; P Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

10.  Coffin-Lowry syndrome associated with calcium pyrophosphate crystal deposition in the ligamenta flava.

Authors:  Y Ishida; T Oki; Y Ono; H Nogami
Journal:  Clin Orthop Relat Res       Date:  1992-02       Impact factor: 4.176

View more
  46 in total

Review 1.  Genetic variation in the epigenetic machinery and mental health.

Authors:  Chris Murgatroyd; Dietmar Spengler
Journal:  Curr Psychiatry Rep       Date:  2012-04       Impact factor: 5.285

Review 2.  X linked mental retardation: a clinical guide.

Authors:  F L Raymond
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

3.  Treatment of drop episodes in Coffin-Lowry syndrome.

Authors:  Sean O'Riordan; M Patton; F Schon
Journal:  J Neurol       Date:  2005-07-20       Impact factor: 4.849

4.  Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulation.

Authors:  Bryan L Roth
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

5.  p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling.

Authors:  Douglas J Sheffler; Wesley K Kroeze; Bonnie G Garcia; Ariel Y Deutch; Sandra J Hufeisen; Patrick Leahy; Jens C Brüning; Bryan L Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-10       Impact factor: 11.205

Review 6.  Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases.

Authors:  John A Allen; Prem N Yadav; Bryan L Roth
Journal:  Neuropharmacology       Date:  2008-07-02       Impact factor: 5.250

7.  Essential role of RSK2 in c-Fos-dependent osteosarcoma development.

Authors:  Jean-Pierre David; Denis Mehic; Latifa Bakiri; Arndt F Schilling; Vice Mandic; Matthias Priemel; Maria Helena Idarraga; Markus O Reschke; Oskar Hoffmann; Michael Amling; Erwin F Wagner
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 8.  Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system.

Authors:  Steven W Flavell; Michael E Greenberg
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

9.  The first large duplication of the RSK2 gene identified in a Coffin-Lowry syndrome patient.

Authors:  Patricia Marques Pereira; Delphine Heron; André Hanauer
Journal:  Hum Genet       Date:  2007-08-24       Impact factor: 4.132

Review 10.  Coffin-Lowry syndrome.

Authors:  Patricia Marques Pereira; Anne Schneider; Solange Pannetier; Delphine Heron; André Hanauer
Journal:  Eur J Hum Genet       Date:  2009-11-04       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.